Dr. Agarwal’s Health Care IPO is creating quite a buzz among investors as its launch approaches. The IPO price band is set at ₹382 to ₹402, with a market lot of 35 shares. The IPO is scheduled to open on January 29. In this article, we’ll cover all the key details you need to know, including the latest updates on its Grey Market Premium (GMP), Kostak rates, and Subject to Sauda trends. Whether you’re a seasoned investor or just starting out, this guide will help you stay informed and confident in making your investment decisions.
Incorporated in 2010, Dr. Agarwal’s Health Care Limited is India’s largest eye care services provider, offering treatments like cataract surgeries, glaucoma care, corneal transplants, and optical products. As of September 30, 2024, the company operates 193 facilities across 117 cities, using an asset-light hub-and-spoke model to deliver accessible care. With 737 skilled doctors, over 2.13 million patients served, and 220,000 surgeries performed in the past year, it has a proven track record of growth and innovation. Backed by a trusted brand and strong management, Dr. Agarwal’s is a leader in India’s healthcare sector.
Overview of Contents
What is Dr. Agarwal’s Health Care IPO GMP
As of today, Dr. Agarwal’s Health Care IPO GMP is ₹-4, signaling a promising start in the grey market. The Dr. Agarwal’s Health Care IPO price band is fixed at ₹382 to ₹402 with a market lot of 35 Shares.
Dr. Agarwal’s Health Care IPO Grey Market Premium Trends
| Date | IPO GMP | GMP Trend | Kostak | Subject to |
|---|---|---|---|---|
| 4 Feb | ₹-4 |  | ₹- | - |
| 3 Feb | ₹-4 | | ₹- | - |
| 2 Feb | ₹0.5 | | ₹- | - |
| 1 Feb | ₹1.5 |  | ₹- | - |
| 31 Jan | ₹0 | | ₹- | 100/1500 |
| 30 Jan | ₹1.5 | | ₹- | 300/4500 |
| 29 Jan | ₹5 | | ₹- | 300/4500 |
| 28 Jan | ₹12 | | ₹- | 300/4500 |
| 27 Jan | ₹13 | | ₹- | 900/13500 |
| 26 Jan | ₹32 | | ₹- | 800/12000 |
| 25 Jan | ₹30 | | ₹- | 1100/16500 |
| 24 Jan | ₹60 | | ₹- | 1600/24000 |
Dr. Agarwal’s Health Care IPO Overview
| Details | Information |
|---|---|
| IPO Date | January 29, 2025, to January 31, 2025 |
| Listing Date | February 5, 2025 |
| Face Value | ₹1 per share |
| Price Band | ₹382 to ₹402 per share |
| Lot Size | 35 Shares |
| Total Issue Size | 7,53,04,970 shares (aggregating up to ₹3,027.26 Cr) |
| Fresh Issue | 74,62,686 shares (aggregating up to ₹300.00 Cr) |
| Offer for Sale | 6,78,42,284 shares of ₹1 (aggregating up to ₹2,727.26 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Pre-Issue Shareholding | 30,84,17,160 shares |
| Post-Issue Shareholding | 31,58,79,846 shares |
| DRHP | Click here |
| RHP | Click Here |
Dr. Agarwal’s Health Care IPO Dates
| Event | Date |
|---|---|
| Subscription Start | Wednesday, January 29, 2025 |
| Subscription Close | Friday, January 31, 2025 |
| Allotment Finalization | Monday, February 3, 2025 |
| Refund Processing Begins | Tuesday, February 4, 2025 |
| Shares Credited to Demat | Tuesday, February 4, 2025 |
| Market Listing Date | Wednesday, February 5, 2025 |
| UPI Mandate Confirmation | By 5 PM on January 31, 2025 |
| Minimum Bid Duration | 3 Working Days |
| Listing Exchanges | BSE, NSE |
FAQs
What is the current GMP for Dr. Agarwal’s Health Care IPO?
The current GMP for Dr. Agarwal’s Health Care IPO is ₹-4.
What is the current Kostak Rate for Dr. Agarwal’s Health Care IPO?
The current Kostak Rate for Dr. Agarwal’s Health Care IPO is ₹-.
What is the current Subject to Sauda for Dr. Agarwal’s Health Care IPO?
The current Subject to Sauda for Dr. Agarwal’s Health Care IPO is ₹-.
Disclaimer:
- The Grey Market Premium (GMP) for Dr. Agarwal’s Health Care IPO reflects the demand in the unofficial market and is valid only for the date mentioned.
- We do not engage in buying or selling IPO forms in the Grey Market.
- Kostak Rate is the premium amount you can earn by selling your IPO application in an off-market transaction before allotment or listing.
- While GMP can provide an indication of market sentiment, it is highly volatile and can change at any time. Relying solely on GMP for investment decisions is risky.
- Investors should focus on the company’s financials, business model, growth potential, and overall fundamentals before subscribing to any IPO. Always make informed decisions to ensure long-term benefits rather than being influenced by short-term market trends.